TORRENT PHARMACEUTICALS LTD. - Outcome of AGM

Following business was transacted at the 44th AGM held on 31st July, 2017:<BR> <BR> 1.Approval and adoption of Standalone and Consolidated Financial Statements.<BR> <BR> 2. Confirmation of payment of interim dividend of Rs 10/- per share & declaration of Rs. 4/- per share as final dividend. <BR> <BR> 3.Re-appointment of Dr. Chaitanya Dutt who retired by rotation. <BR> <BR> 4.Appointment of BSR & Co., LLP, Chartered Accountants as Statutory Auditors to hold office from the conclusion of this 44th AGM until the conclusion of the 49th AGM subject to ratification by members every year & to authorize Board to fix their remuneration.<BR> <BR> 5.Ratification of remuneration of cost auditors. <BR> <BR> 6.Re-appointment of Dr. Chaitanya Dutt as Whole Time Director and fixation of his remuneration.<BR> <BR> 7.Issuance of Redeemable Non-Convertible Debentures / Bonds by way of Private Placement.<BR> <BR> Above business was transacted by e-voting and Poll, results of passing of above resolutions will be disclosed to the Stock Exchange separately.<BR>